Treatment with alpha ‐galactosylceramide protects mice from early onset of non‐alcoholic steatohepatitis: role of intestinal barrier function
ConclusionTaken together, our data suggest that the protective effects of αGalCer against the development of a diet‐induced NASH in mice are associated with a protection against the increased translocation of intestinal bacterial endotoxins associated with the development of NASH.This article is protected by copyright. All rights reserved
Source: Nahrung / Food - Category: Nutrition Authors: Anna Janina Engstler, Cathrin Sellmann, Cheng Jun Jin, Annette Brandt, Kathleen Herz, Josephine Priebs, Ina Bergheim Tags: Research Article Source Type: research
More News: Alcoholism | Fatty Liver Disease (FLD) | Liver | Liver Disease | Nutrition | Translocation | Urology & Nephrology